T&W Medical A/S: Financial statements 2015
CVR: 28511809
Source: annual report 2015, Danish Business Authority
01/05/2014 – 30/04/2015
T&W Medical A/S (CVR 28511809) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 0 and a net result of DKK 33,783,000 compared with DKK -261,046,000 the year before. Equity in the 2015 report amounted to DKK 1,156,092,000. The solvency ratio was 48.8%. The company had 3,700 employees in the financial year.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 33,783,000
- Equity
- DKK 1,156,092,000
- Total Assets
- DKK 2,370,189,000
- Employees
- 3,700
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 0 | 0 | 33.8M | 1.2B | 3700 |
| 2014 | 0 | 0 | -261M | 1B | 3604 |
| 2013 | 0 | 0 | -368M | 393.1M | 3682 |
Official annual report
How creditworthy is T&W Medical A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of April 22, 2015, Richard Tøpholm has joined the board of directors of T&W Medical A/S.
As of April 22, 2015, Julian Tøpholm has joined the board of directors of T&W Medical A/S.
As of April 22, 2015, Lars Nørgaard is registered as director of T&W Medical A/S.
As of April 22, 2015, Anders Steen Westermann has stepped down as director of T&W Medical A/S.
About T&W Medical A/S
T&W Medical A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 2005. The company is registered under the industry Ikke-finansielle hovedsæders aktiviteter. The company was previously named WIDEX HOLDING A/S. The management consists of Lars Nørgaard. The board consists of Jan Tøpholm (chair), Adam Westermann, Anders Steen Westermann and Julian Tøpholm. The company's owners include Anders Steen Westermann, Jan Tøpholm and Søren Erik Westermann. The company has 22 employees (2026). In 2025, the company reported revenue of DKK 19,251,000,000 and a net result of DKK -347,000,000 compared with DKK -9,314,000,000 the year before. Equity in the 2025 report amounted to DKK 9,983,000,000.
